Targeted Protein Degradation by Chimeric Small Molecules, PROTACs and SNIPERs

Area of Science:

• Biochemistry
• Molecular Biology
• Drug Discovery

Background:

• Targeted protein degradation is a rapidly advancing field.
• Small molecules are being developed to induce degradation of specific proteins.
• Existing methods include Proteolysis Targeting Chimeras (PROTACs) and Specific and Non-genetic IAP-dependent Protein Erasers (SNIPERs), alongside E3 modulators like thalidomides.

Purpose of the Study:

• To review recent advancements in small molecule-induced targeted protein degradation.
• To highlight the mechanisms by which these technologies hijack cellular machinery.
• To underscore the potential for targeting previously undruggable proteins.

Main Methods:

• Review of recent literature on targeted protein degradation technologies.
• Analysis of mechanisms involving ubiquitylation and proteasomal degradation.
• Discussion of small molecule modalities like PROTACs, SNIPERs, and E3 modulators.

Main Results:

• Small molecule technologies effectively induce targeted protein degradation.
• These technologies utilize the cell's natural ubiquitylation and proteasomal pathways.
• A wide range of proteins, including previously 'undruggable' targets, can now be degraded.

Conclusions:

• Targeted protein degradation represents a significant breakthrough in drug discovery.
• These technologies offer novel therapeutic strategies for various diseases.
• The field holds immense promise for both academic research and industrial drug development.